Skip to main content
NCBI home page
Heart logoLink to Heart
. 1996 Apr;75(4):330–333. doi: 10.1136/hrt.75.4.330

Cardioprotection: definition, classification, and fundamental principles.

W Kübler 1, M Haass 1
PMCID: PMC484304  PMID: 8705755

Full text

PDF
330

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bristow M. R. Changes in myocardial and vascular receptors in heart failure. J Am Coll Cardiol. 1993 Oct;22(4 Suppl A):61A–71A. doi: 10.1016/0735-1097(93)90465-d. [DOI] [PubMed] [Google Scholar]
  2. Cohn J. N., Archibald D. G., Ziesche S., Franciosa J. A., Harston W. E., Tristani F. E., Dunkman W. B., Jacobs W., Francis G. S., Flohr K. H. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986 Jun 12;314(24):1547–1552. doi: 10.1056/NEJM198606123142404. [DOI] [PubMed] [Google Scholar]
  3. Cohn J. N., Johnson G., Ziesche S., Cobb F., Francis G., Tristani F., Smith R., Dunkman W. B., Loeb H., Wong M. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991 Aug 1;325(5):303–310. doi: 10.1056/NEJM199108013250502. [DOI] [PubMed] [Google Scholar]
  4. Cohn J. N., Levine T. B., Olivari M. T., Garberg V., Lura D., Francis G. S., Simon A. B., Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984 Sep 27;311(13):819–823. doi: 10.1056/NEJM198409273111303. [DOI] [PubMed] [Google Scholar]
  5. Dart A. M., Schömig A., Dietz R., Mayer E., Kübler W. Release of endogenous catecholamines in the ischemic myocardium of the rat. Part B: Effect of sympathetic nerve stimulation. Circ Res. 1984 Nov;55(5):702–706. doi: 10.1161/01.res.55.5.702. [DOI] [PubMed] [Google Scholar]
  6. Feigl E. O. Coronary physiology. Physiol Rev. 1983 Jan;63(1):1–205. doi: 10.1152/physrev.1983.63.1.1. [DOI] [PubMed] [Google Scholar]
  7. Feldman A. M., Cates A. E., Veazey W. B., Hershberger R. E., Bristow M. R., Baughman K. L., Baumgartner W. A., Van Dop C. Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. J Clin Invest. 1988 Jul;82(1):189–197. doi: 10.1172/JCI113569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hammermeister K. E., DeRouen T. A., Dodge H. T. Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations. Circulation. 1979 Mar;59(3):421–430. doi: 10.1161/01.cir.59.3.421. [DOI] [PubMed] [Google Scholar]
  9. Harden T. K. Agonist-induced desensitization of the beta-adrenergic receptor-linked adenylate cyclase. Pharmacol Rev. 1983 Mar;35(1):5–32. [PubMed] [Google Scholar]
  10. Kübler W., Spieckermann P. G. Changes in glycolysis and in high-energy phosphates during myocardial ischemia with intermittent coronary perfusion. Cardiology. 1971;56(1):100–107. doi: 10.1159/000169349. [DOI] [PubMed] [Google Scholar]
  11. Kübler W., Spieckermann P. G. Regulation of glycolysis in the ischemic and the anoxic myocardium. J Mol Cell Cardiol. 1970 Dec;1(4):351–377. doi: 10.1016/0022-2828(70)90034-9. [DOI] [PubMed] [Google Scholar]
  12. Kübler W., Strasser R. H. Signal transduction in myocardial ischaemia. Eur Heart J. 1994 Apr;15(4):437–445. doi: 10.1093/oxfordjournals.eurheartj.a060523. [DOI] [PubMed] [Google Scholar]
  13. Kübler W. Tierexperimentelle Untersuchungen zum Myokardstoffwechsel im Angina-pectoris-Anfall und beim Herzinfarkt. Bibl Cardiol. 1969;22:1–93. [PubMed] [Google Scholar]
  14. Lawson C. S., Downey J. M. Preconditioning: state of the art myocardial protection. Cardiovasc Res. 1993 Apr;27(4):542–550. doi: 10.1093/cvr/27.4.542. [DOI] [PubMed] [Google Scholar]
  15. Levy D., Anderson K. M., Savage D. D., Balkus S. A., Kannel W. B., Castelli W. P. Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol. 1987 Sep 1;60(7):560–565. doi: 10.1016/0002-9149(87)90305-5. [DOI] [PubMed] [Google Scholar]
  16. Murry C. E., Jennings R. B., Reimer K. A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986 Nov;74(5):1124–1136. doi: 10.1161/01.cir.74.5.1124. [DOI] [PubMed] [Google Scholar]
  17. Neumann J., Schmitz W., Scholz H., von Meyerinck L., Döring V., Kalmar P. Increase in myocardial Gi-proteins in heart failure. Lancet. 1988 Oct 22;2(8617):936–937. doi: 10.1016/s0140-6736(88)92601-3. [DOI] [PubMed] [Google Scholar]
  18. Pfeffer M. A., Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990 Apr;81(4):1161–1172. doi: 10.1161/01.cir.81.4.1161. [DOI] [PubMed] [Google Scholar]
  19. Rahimtoola S. H. The hibernating myocardium. Am Heart J. 1989 Jan;117(1):211–221. doi: 10.1016/0002-8703(89)90685-6. [DOI] [PubMed] [Google Scholar]
  20. Rector T. S., Cohn J. N. Prognosis in congestive heart failure. Annu Rev Med. 1994;45:341–350. doi: 10.1146/annurev.med.45.1.341. [DOI] [PubMed] [Google Scholar]
  21. Richardt G., Waas W., Kranzhöfer R., Mayer E., Schömig A. Adenosine inhibits exocytotic release of endogenous noradrenaline in rat heart: a protective mechanism in early myocardial ischemia. Circ Res. 1987 Jul;61(1):117–123. doi: 10.1161/01.res.61.1.117. [DOI] [PubMed] [Google Scholar]
  22. Starke K. Presynaptic receptors. Annu Rev Pharmacol Toxicol. 1981;21:7–30. doi: 10.1146/annurev.pa.21.040181.000255. [DOI] [PubMed] [Google Scholar]
  23. Tauchert M. Koronarreserve und maximaler Sauerstoffverbrauch des menschlichen Herzens. Basic Res Cardiol. 1973 Mar-Apr;68(2):183–223. doi: 10.1007/BF01906424. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES